BioOrbit
PrivateLast Round
Seed
Apr 30, 2026
Total Funding Raised
$16.08M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioOrbit operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in April 2026.
BioOrbit is a biotechnology company that operates a pharmaceutical factory for the large-scale crystallization of protein drugs in microgravity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Space Technology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioOrbit Comparables
Compare BioOrbit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Space LiinTech | 84% | |
| Frontier Space Technologies | 81% | |
| SpacePharma | 78% |
For institutional investors. Book with your work email.
BioOrbit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 30, 2026 | ||||
| Grant | Feb 9, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioOrbit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 7 Percent Ventures | Seed, Pre Seed |
| Breega | Seed |
| Phoenix Court Group | Seed |
| Type One Ventures | Seed, Pre Seed |
| UK Space Agency | Grant |
| Seedcamp | Seed, Pre Seed |
| Auxxo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
Open roles increased to 9, double the trailing average.
- Aug 3, 2026
Open roles increased to 8, 3.3x the trailing average.
For institutional investors. Book with your work email.
BioOrbit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioOrbit's valuation, stock price, and market status.
Is BioOrbit a public or private company?
BioOrbit is a private company.
What is the current stock price of BioOrbit?
BioOrbit is a private company, so its shares have no public market price. Caplight tracks BioOrbit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioOrbit worth (valuation)?
Valuation information for BioOrbit is not publicly available.
Can I buy BioOrbit stock?
BioOrbit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioOrbit's last funding round?
BioOrbit's most recent funding round was Seed on April 30, 2026.
Who are the main investors in BioOrbit?
Key investors in BioOrbit include Breega, Phoenix Court Group.
Will BioOrbit IPO soon?
No public IPO plans have been announced for BioOrbit.
How can I track BioOrbit secondary market activity?
Caplight tracks bids, offers, and trades in BioOrbit's shares on secondary markets.